PT2182988E - Composição radiofarmacêutica - Google Patents
Composição radiofarmacêutica Download PDFInfo
- Publication number
- PT2182988E PT2182988E PT88033014T PT08803301T PT2182988E PT 2182988 E PT2182988 E PT 2182988E PT 88033014 T PT88033014 T PT 88033014T PT 08803301 T PT08803301 T PT 08803301T PT 2182988 E PT2182988 E PT 2182988E
- Authority
- PT
- Portugal
- Prior art keywords
- radiopharmaceutical composition
- radiopharmaceutical
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0453—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US96890407P | 2007-08-30 | 2007-08-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2182988E true PT2182988E (pt) | 2014-05-16 |
Family
ID=40029249
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT88033014T PT2182988E (pt) | 2007-08-30 | 2008-08-28 | Composição radiofarmacêutica |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US8916131B2 (pt) |
| EP (1) | EP2182988B1 (pt) |
| JP (1) | JP5367708B2 (pt) |
| KR (1) | KR101571572B1 (pt) |
| CN (1) | CN101790387B (pt) |
| AU (1) | AU2008292201B2 (pt) |
| BR (1) | BRPI0815129B8 (pt) |
| CA (1) | CA2694084C (pt) |
| DK (1) | DK2182988T3 (pt) |
| ES (1) | ES2464715T3 (pt) |
| HK (1) | HK1146710A1 (pt) |
| HU (1) | HUS1500007I1 (pt) |
| IL (1) | IL203316A (pt) |
| MX (1) | MX2010002196A (pt) |
| NO (1) | NO2015006I1 (pt) |
| NZ (1) | NZ583616A (pt) |
| PL (1) | PL2182988T3 (pt) |
| PT (1) | PT2182988E (pt) |
| RU (1) | RU2475267C2 (pt) |
| WO (1) | WO2009027452A2 (pt) |
| ZA (1) | ZA201000718B (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2509637T (pt) * | 2009-10-08 | 2016-10-05 | Ge Healthcare Ltd | Processo de purificação |
| ES2725314T3 (es) * | 2012-04-10 | 2019-09-23 | Lantheus Medical Imaging Inc | Métodos de síntesis radiofarmacéutica |
| RU2719399C2 (ru) | 2014-12-04 | 2020-04-17 | ДжиИ ХЕЛТКЕР ЛИМИТЕД | Способ удаления ацетальдегида из радиоактивных фармацевтических препаратов |
| JP6485914B2 (ja) * | 2015-10-28 | 2019-03-20 | 日本メジフィジックス株式会社 | フルテメタモルの製造方法 |
| JP6955347B2 (ja) | 2017-02-28 | 2021-10-27 | 日本メジフィジックス株式会社 | フルテメタモルの製造方法 |
| CN109400615B (zh) * | 2017-08-18 | 2021-07-16 | 上海交通大学医学院附属新华医院 | 一种靶向β-淀粉样蛋白的香豆素类化合物及其制备与应用 |
| WO2021195414A1 (en) * | 2020-03-27 | 2021-09-30 | Jubilant Pharma Holdings Inc. | Radiopharmaceutical dispensing system |
| US11980685B1 (en) | 2022-12-23 | 2024-05-14 | Tap Pharmaceuticals, Ag | Liquid pharmaceutical formulations of tafamidis |
| US11878081B1 (en) | 2022-12-23 | 2024-01-23 | Tap Pharmaceuticals Ag | Pharmaceutical formulations of tafamidis |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4335095A (en) * | 1979-03-21 | 1982-06-15 | The Radiochemical Centre Limited | Indium-111 oxine complex composition |
| GB9919673D0 (en) * | 1999-08-20 | 1999-10-20 | Cancer Res Campaign Tech | 2-Arlybenzazole compounds |
| ES2536449T3 (es) | 2000-08-24 | 2015-05-25 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Derivados de tioflavina para uso en diagnosis de la enfermedad de Alzheimer |
| EP1474178A1 (en) * | 2002-02-13 | 2004-11-10 | Amersham plc | Benzothiazole derivatives for in vivo imaging of amyloid plaques |
| CA2438032C (en) * | 2003-03-14 | 2013-05-07 | University Of Pittsburgh | Benzothiazole derivative compounds, compositions and uses |
| US20050043523A1 (en) * | 2003-08-22 | 2005-02-24 | University Of Pittsburgh | Benzothiazole derivative compounds, compositions and uses |
| BRPI0512893B8 (pt) | 2004-07-02 | 2021-07-27 | Univ Pittsburgh | métodos de determinação da eficácia da terapia no tratamento da amiloidose e de identificação de paciente como prodrômico para doença associada com a deposição amilóide e respectivos compostos |
| JP2008505116A (ja) * | 2004-07-02 | 2008-02-21 | ユニバーシティー オブ ピッツバーグ | アミロイド沈着を伴う疾患の前駆形態の診断方法 |
| AU2006261917A1 (en) * | 2005-06-24 | 2007-01-04 | The Trustees Of The University Of Pennsylvania | Radiolabeled-pegylation of ligands for use as imaging agents |
| GB0516564D0 (en) * | 2005-08-12 | 2005-09-21 | Ge Healthcare Ltd | Fluorination process |
| JP2009519239A (ja) * | 2005-12-01 | 2009-05-14 | ユニバーシティ オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケーション | アミロイド生成性タンパク質の造影剤としての同位体標識ベンゾチアゾール化合物 |
| WO2008134618A2 (en) | 2007-04-27 | 2008-11-06 | The General Hospital Corporation | Novel imaging tracers for early detection and treatment of amyloid plaques caused by alzheimer's disease and related disorders |
-
2008
- 2008-08-28 PL PL08803301T patent/PL2182988T3/pl unknown
- 2008-08-28 JP JP2010522366A patent/JP5367708B2/ja active Active
- 2008-08-28 WO PCT/EP2008/061275 patent/WO2009027452A2/en active Application Filing
- 2008-08-28 RU RU2010101935/15A patent/RU2475267C2/ru active
- 2008-08-28 DK DK08803301.4T patent/DK2182988T3/da active
- 2008-08-28 BR BRPI0815129A patent/BRPI0815129B8/pt active IP Right Grant
- 2008-08-28 PT PT88033014T patent/PT2182988E/pt unknown
- 2008-08-28 CN CN2008801048119A patent/CN101790387B/zh active Active
- 2008-08-28 EP EP08803301.4A patent/EP2182988B1/en active Active
- 2008-08-28 NZ NZ583616A patent/NZ583616A/en unknown
- 2008-08-28 MX MX2010002196A patent/MX2010002196A/es active IP Right Grant
- 2008-08-28 AU AU2008292201A patent/AU2008292201B2/en active Active
- 2008-08-28 US US12/673,602 patent/US8916131B2/en active Active
- 2008-08-28 KR KR1020107004301A patent/KR101571572B1/ko active IP Right Grant
- 2008-08-28 ES ES08803301.4T patent/ES2464715T3/es active Active
- 2008-08-28 CA CA2694084A patent/CA2694084C/en active Active
-
2010
- 2010-01-14 IL IL203316A patent/IL203316A/en active IP Right Grant
- 2010-01-29 ZA ZA201000718A patent/ZA201000718B/xx unknown
-
2011
- 2011-01-27 HK HK11100867.7A patent/HK1146710A1/xx unknown
-
2015
- 2015-02-18 NO NO2015006C patent/NO2015006I1/no not_active IP Right Cessation
- 2015-02-18 HU HUS1500007C patent/HUS1500007I1/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0815129B8 (pt) | 2021-05-25 |
| RU2475267C2 (ru) | 2013-02-20 |
| ES2464715T3 (es) | 2014-06-03 |
| RU2010101935A (ru) | 2011-10-10 |
| WO2009027452A3 (en) | 2009-09-03 |
| JP2010536931A (ja) | 2010-12-02 |
| CA2694084A1 (en) | 2009-03-05 |
| CA2694084C (en) | 2015-07-07 |
| CN101790387A (zh) | 2010-07-28 |
| NO2015006I2 (pt) | 2015-02-18 |
| DK2182988T3 (da) | 2014-05-26 |
| JP5367708B2 (ja) | 2013-12-11 |
| AU2008292201B2 (en) | 2014-09-04 |
| IL203316A (en) | 2015-02-26 |
| EP2182988A2 (en) | 2010-05-12 |
| ZA201000718B (en) | 2010-10-27 |
| CN101790387B (zh) | 2013-03-20 |
| PL2182988T3 (pl) | 2015-02-27 |
| US8916131B2 (en) | 2014-12-23 |
| WO2009027452A2 (en) | 2009-03-05 |
| BRPI0815129B1 (pt) | 2021-01-12 |
| KR20100055440A (ko) | 2010-05-26 |
| HUS1500007I1 (hu) | 2021-05-07 |
| EP2182988B1 (en) | 2014-04-16 |
| US20110008254A1 (en) | 2011-01-13 |
| NO2015006I1 (no) | 2015-03-02 |
| KR101571572B1 (ko) | 2015-11-24 |
| AU2008292201A1 (en) | 2009-03-05 |
| BRPI0815129A2 (pt) | 2015-02-03 |
| HK1146710A1 (en) | 2011-07-08 |
| MX2010002196A (es) | 2010-03-18 |
| NZ583616A (en) | 2012-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0718777D0 (en) | Composition | |
| GB0700534D0 (en) | Composition | |
| GB0717182D0 (en) | Composition | |
| HK1149203A1 (en) | Improved radiopharmaceutical composition | |
| GB0722550D0 (en) | Composition | |
| HUS1500007I1 (hu) | Radiogyógyszerészeti kompozíció | |
| GB0714575D0 (en) | Composition | |
| GB0710888D0 (en) | Composition | |
| GB0716591D0 (en) | Composition | |
| GB0714569D0 (en) | Composition | |
| GB0706343D0 (en) | Composition | |
| GB0705885D0 (en) | Composition | |
| GB0702446D0 (en) | Composition | |
| GB0703719D0 (en) | Composition | |
| GB0706739D0 (en) | Composition | |
| GB0704651D0 (en) | Composition | |
| GB0707972D0 (en) | Composition | |
| GB0721430D0 (en) | Composition | |
| GB0713976D0 (en) | Composition | |
| GB0710559D0 (en) | Composition | |
| GB0704659D0 (en) | Composition | |
| GB0716875D0 (en) | Novel radiopharmaceutical formulation | |
| GB0717601D0 (en) | Composition | |
| GB0717386D0 (en) | Composition | |
| GB0715705D0 (en) | Composition |